19 articles for D Dhanak
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.
Glaxosmithkline
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.
TBA
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase.
Glaxosmithkline
Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase.
Smithkline Beecham Pharmaceuticals
Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
Glaxosmithkline
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.
Johns Hopkins University
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.
Cytokinetics Inc
GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models.
GlaxoSmithKline
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.
GlaxoSmithKline
Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1.
GlaxoSmithKline
3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Glaxosmithkline
Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture.
Glaxosmithkline
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
Smithkline Beecham Pharmaceuticals
Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.
Smithkline Beecham Pharmaceuticals
Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
Smithkline Beecham Pharmaceuticals
Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease.
Smithkline Beecham Pharmaceuticals
